Article
Low Prevalence of the Somatic M918T <i>RET</i> Mutation in Micro-Medullary Thyroid Cancer
9 Mar 2012
Abstract excerpt
BACKGROUND: The prevalence of RET somatic mutations in sporadic medullary thyroid cancer (MTCs) is ∼40%-50%, and the most frequent somatic mutation is M918T. RET-positive MTCs have been demonstrated to have a more advanced stage at diagnosis and a worse outcome. AIMS: The aim of the present work was to compare the prevalence of RET somatic mutations in sporadic microMTCs (<1 cm) and in larger MTCs. PATIENTS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
